TABLE 24Resource use and costs due to systemic reactions to sting for patients in avoidance advice-only arm

Grade 1Grade 2Grade 3Grade 4
Resource useCost (£)Resource useCost (£)Resource useCost (£)Resource useCost (£)
A&E visit100% of patients103100% of patients103100% of patients103100% of patients103
Inpatient stay0% of patients010% of patients3530% of patients10550% of patients175
Antihistamine1 dose0.141 dose0.141 dose0.141 dose0.14
Adrenaline1 ampoule0.671 ampoule0.671 ampoule0.671 ampoule0.67
Total cost103.81138.81108.81178.81

From: 4, Assessment of cost-effectiveness

Cover of A Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Pharmalgen® for the Treatment of Bee and Wasp Venom Allergy
A Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Pharmalgen® for the Treatment of Bee and Wasp Venom Allergy.
Health Technology Assessment, No. 16.12.
Hockenhull J, Elremeli M, Cherry MG, et al.
Southampton (UK): NIHR Journals Library; 2012 Mar.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.